Related Experiment Video
Updated: Mar 28, 2026
10:03
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
960
Biomarkers in paediatric heart failure: is there value?
11Division of Cardiology,The Children's Hospital of Philadelphia,Philadelphia,Pennsylvania,United States of America.
Cardiology in the Young
|December 18, 2015
Summary
Serum biomarkers offer a low-cost, accessible method for detecting pediatric heart failure. This review explores their potential in aiding diagnosis and prognosis for improved clinical decision-making.
Area of Science:
- Biomarkers
- Pediatric Cardiology
- Heart Failure
Background:
- Biomarkers are measurable indicators of disease states, including blood tests, imaging, and genetic profiles.
- Serum biomarkers are advantageous due to low cost, minimal risk, and ease of sample collection.
- Effective biomarkers can significantly aid in clinical decision-making, diagnosis, and prognosis.
Observation:
- This manuscript focuses on serum biomarkers for pediatric heart failure.
- The utility of these biomarkers in clinical practice is reviewed.
- Emphasis is placed on their role in diagnosis and prognosis.
Findings:
- Serum biomarkers present a valuable tool in managing pediatric heart failure.
- Their application can enhance diagnostic accuracy and prognostic assessment.
- Review identifies key serum biomarkers with potential clinical utility.
Implications:
- Improved diagnostic and prognostic capabilities for pediatric heart failure.
- Potential for earlier intervention and more personalized treatment strategies.
- Enhanced clinical decision-making through reliable biomarker data.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
742
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
742
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
01:29Heart Failure II: Pathophysiology
1.4K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
01:17Pathophysiology of Heart Failure
4.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
01:26Heart Failure III: Clinical Manifestations
846
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
846
01:30Heart Failure IV: Classification and Diagnostic Evaluation
580
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
580